Valuation: Consun Pharmaceutical Group Limited

Market Cap 11.22B 13.16B 1.68B 1.49B 1.38B 1.26B 2.37B 159B 2.41B 16.6B 6.51B 83.03B 6.29B 6.16B 265B P/E 2026 *
9.22x
P/E 2027 * 8.37x
Enterprise Value 11.22B 13.16B 1.68B 1.49B 1.38B 1.26B 2.37B 159B 2.41B 16.6B 6.51B 83.03B 6.29B 6.16B 265B EV / Sales 2026 *
2.89x
EV / Sales 2027 * 2.58x
Free-Float
54.14%
Yield 2026 *
5.42%
Yield 2027 * 5.98%
1 day+1.88%
1 week+5.59%
Current month+5.66%
1 month+19.06%
3 months+15.46%
6 months-3.86%
Current year+0.26%
1 week 14.85
Extreme 14.85
15.84
1 month 13.43
Extreme 13.43
15.84
Current year 12.31
Extreme 12.31
19.49
1 year 12.31
Extreme 12.31
19.49
3 years 4.31
Extreme 4.31
19.49
5 years 2.92
Extreme 2.92
19.49
10 years 2.61
Extreme 2.61
19.49
Manager TitleAgeSince
Chief Executive Officer 54 2024-01-16
Director of Finance/CFO 46 2025-02-23
Corporate Secretary 58 -
Director TitleAgeSince
Director/Board Member 86 2012-12-23
Director/Board Member 67 2013-12-01
Chairman 54 2021-07-08
Date Insider Type Main position Quantity % Market Cap. Importance
7/17/25 Other

Chief Executive Officer

50,000 0.0059%
7/17/25 Other

Chief Executive Officer

50,000 0.0059%
7/15/25 Other

Chief Executive Officer

136,000 0.0160%
Change 5-day change 1-year change 3-year change Capi.($)
+1.88%+5.59%+4.05%+234.33% 1.68B
+0.43%+6.59%+56.57%+106.64% 1,120B
+0.90%-2.25%+32.26%+63.73% 616B
+0.71%+3.24%+24.33%+91.33% 504B
-0.13%+5.98%+33.66%+50.18% 367B
+0.52%+0.24%+72.13%+40.11% 360B
-0.95%+4.70%+19.65%+42.71% 288B
-1.98%+3.73%-0.89%+10.43% 258B
-0.35%+4.25%+44.74%+52.06% 234B
-0.75%+3.32%+27.18%+94.07% 194B
Average +0.03%+3.81%+31.37%+78.56% 394.26B
Weighted average by Cap. +0.13%+3.83%+39.32%+71.89%

Financials

2026 *2027 *
Net sales 3.88B 4.55B 580M 516M 478M 435M 821M 55.07B 834M 5.75B 2.25B 28.74B 2.18B 2.13B 91.6B 4.35B 5.1B 650M 578M 536M 487M 920M 61.71B 935M 6.44B 2.52B 32.2B 2.44B 2.39B 103B
Net income 1.24B 1.45B 185M 164M 152M 138M 261M 17.53B 265M 1.83B 717M 9.15B 693M 678M 29.16B 1.36B 1.6B 204M 181M 168M 153M 288M 19.33B 293M 2.02B 791M 10.09B 764M 748M 32.15B
Net Debt - -
Projected Income Statement - Annual - Consun Pharmaceutical Group Limited
Logo Consun Pharmaceutical Group Limited
Consun Pharmaceutical Group Ltd is a company principally engaged in manufacturing and sales of pharmaceutical products. The Company operates its businesses through two segments. Consun Pharmaceutical segment is mainly engaged in manufacturing and sells of modern Chinese medicines and medical contrast medium. Yulin Pharmaceutical segment is mainly involved in manufacturing and sells of traditional Chinese medicines. The Company's products include kidney medicines, gynaecology and paediatrics medicines, contrast medium, orthopedics medicines, dermatologic medicines, hepatobiliary medicines and others. The Company mainly operates its businesses in the domestic market.
Employees
2,847
Date Price Change Volume
26-10-16 HK$15.68 +1.88% 1,352,102
26-10-15 HK$15.39 +2.53% 2,062,204
26-10-14 HK$15.01 -1.18% 2,319,662
26-10-13 HK$15.19 +0.53% 1,368,000
26-10-12 HK$15.11 +1.75% 1,689,000
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Consun Pharmaceutical Group Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
13.37CNY
Average target price
19.36CNY
Spread / Average Target
+44.78%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Consun Pharmaceutical Group Limited
  1. Stock Market
  2. Stocks
  3. 1681 Stock